Notable Labs, Ltd. (NTBL)
USD 0.25
(-27.68%)
USD 0.25
(-27.68%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -13.71 Million | -11.64 Million | -15.05 Million | -23.37 Million | -13.08 Million | -15.68 Million |
| Net Income | -11.26 Million | -14.4 Million | -16.05 Million | -24.22 Million | -19.39 Million | -20.45 Million |
| Depreciation & Amortization | 257 Thousand | 323 Thousand | 326 Thousand | 1.19 Million | 1.21 Million | 1.15 Million |
| Deferred income taxes | -3.21 Million | 1.52 Million | -801 Thousand | - | - | - |
| Stock-based compensation | 589 Thousand | 581 Thousand | 779 Thousand | - | - | - |
| Change in working capital | -698 Thousand | 114 Thousand | 96 Thousand | -2.07 Million | 2.61 Million | -240 Thousand |
| Other non-cash items | 614 Thousand | 225 Thousand | 599 Thousand | 5.61 Million | 2.77 Million | 5.86 Million |
| Investing Cash Flow | 15.54 Million | 924 Thousand | 14.75 Million | 9.89 Million | -6.1 Million | 24.73 Million |
| Investments in PPE | -65 Thousand | -41 Thousand | -441 Thousand | -51 Thousand | -73 Thousand | -2.22 Million |
| Acquisitions | 15.6 Million | - | - | - | - | 4000.00 |
| Investment purchases | - | -594 Thousand | -4.89 Million | -41.08 Million | -63.02 Million | - |
| Sales/Maturities of investments | - | 1.46 Million | 20.09 Million | 51.02 Million | 57 Million | 26.95 Million |
| Other Investing Activities | - | 95 Thousand | - | - | - | - |
| Financing Cash Flow | 7.82 Million | 9.89 Million | 1.06 Million | 17.06 Million | -359 Thousand | 13.67 Million |
| Debt repayment | -63 Thousand | - | -104 Thousand | -391 Thousand | -361 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 22 Thousand | 49.21 Million | 17.45 Million | 2000.00 | 13.75 Million |
| Other Financing Activities | 3.89 Million | 4 Million | - | - | - | -88 Thousand |
| Accounts receivables | - | - | 129 Thousand | -129 Thousand | - | 2 Million |
| Accounts payables | 772 Thousand | 104 Thousand | 52 Thousand | -1.37 Million | 2.13 Million | -1.69 Million |
| Inventory | - | - | -129 Thousand | - | - | - |
| Other working capital | -1.47 Million | 10 Thousand | 44 Thousand | -577 Thousand | 482 Thousand | -549 Thousand |
| Cash at beginning of period | 1.58 Million | 2.4 Million | 1.62 Million | 9.43 Million | 29.34 Million | 6.69 Million |
| Cash at end of period | 11.82 Million | 1.58 Million | 2.4 Million | 13.33 Million | 9.43 Million | 29.34 Million |
| Capital Expenditure | -65 Thousand | -41 Thousand | -441 Thousand | -51 Thousand | -73 Thousand | -2.22 Million |
| Effect of forex changes on cash | 598 Thousand | - | - | 319 Thousand | -363 Thousand | - |
| Net cash flow / Change in cash | 10.24 Million | -820 Thousand | 772 Thousand | 3.89 Million | -19.91 Million | 22.65 Million |
| Free Cash Flow | -13.78 Million | -11.68 Million | -15.49 Million | -23.42 Million | -13.16 Million | -17.9 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.21 Million | -3.76 Million | -11.26 Million | -874 Thousand | -2.63 Million | -14.4 Million |
| Depreciation & Amortization | 64 Thousand | 63 Thousand | 257 Thousand | 62 Thousand | 68 Thousand | 323 Thousand |
| Deferred income taxes | - | - | -3.21 Million | - | - | 1.52 Million |
| Stock-based compensation | 919 Thousand | 132 Thousand | 589 Thousand | 202 Thousand | 116 Thousand | 581 Thousand |
| Change in working capital | 512 Thousand | -92 Thousand | -698 Thousand | -2.12 Million | 1.42 Million | 114 Thousand |
| Other non-cash items | 114 Thousand | 113 Thousand | 614 Thousand | 1.08 Million | -603.99 Thousand | 225 Thousand |
| Investing Cash Flow | -9000.00 | -6000.00 | 15.54 Million | 20.7 Thousand | 10.1 Million | 924 Thousand |
| Investments in PPE | -9000.00 | -6000.00 | -65 Thousand | -26 Thousand | -4000.00 | -41 Thousand |
| Acquisitions | - | - | 15.6 Million | - | - | - |
| Investment purchases | - | - | - | - | - | -594 Thousand |
| Sales/Maturities of investments | - | - | - | -48.2 Thousand | 3 Million | 1.46 Million |
| Other Investing Activities | -1000.00 | - | - | 68.91 Thousand | 7.1 Million | 95 Thousand |
| Financing Cash Flow | -325 Thousand | -19 Thousand | 7.82 Million | 983.93 | 4.34 Million | 9.89 Million |
| Debt repayment | -19 Thousand | -19 Thousand | -63 Thousand | -18 Thousand | -7000.00 | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 983.93 | - | 22 Thousand |
| Other Financing Activities | -306 Thousand | - | 3.89 Million | 1.84 Million | 4.35 Million | 4 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -377 Thousand | -250 Thousand | 772 Thousand | -377.91 Thousand | 128 Thousand | 104 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 880.41 Thousand | - | -1.47 Million | -1.75 Million | 1.29 Million | 10 Thousand |
| Cash at beginning of period | 8.17 Million | 11.82 Million | 1.58 Million | 26.45 Million | 18.02 Million | 2.4 Million |
| Cash at end of period | 4.09 Million | 8.17 Million | 11.82 Million | 24.26 Million | 26.45 Million | 1.58 Million |
| Capital Expenditure | -9000.00 | -6000.00 | -65 Thousand | -26 Thousand | -4000.00 | -41 Thousand |
| Effect of forex changes on cash | -35 Thousand | -68 Thousand | 598 Thousand | 85.22 Thousand | - | - |
| Net cash flow / Change in cash | -4.07 Million | -3.65 Million | 10.24 Million | -2.19 Million | 8.42 Million | -820 Thousand |
| Free Cash Flow | -3.71 Million | -3.56 Million | -13.78 Million | -2.32 Million | -1.69 Million | -11.68 Million |
QLT
GENUSPRIME
8480
SMIN
2331
LXRX